Most Recent
Cbus trustee must pay $23.5M in ASIC case over delayed death benefits
A judge has ordered trustee United Super to pay $23.5 million after admitting it was liable for excessive delays in processing $20 million in death and disability claims.
Cbus admits liability in ASIC death benefit case, faces penalty hearing
Super fund Cbus has made admissions in the corporate regulator's case over long delays in the processing of $20 million in death and disability claims, with the action to progress directly to penalty.
‘Inordinate and disproportionate’: Judge slams ASIC’s case against lender Money3
A judge has rejected all but two claims by ASIC in a suit against car finance provider Money3 and criticised how the regulator ran its case, saying it had consumed an "inordinate and disproportionate amount of the judicial and administrative resources of the court".
‘No urgency’: Judge rejects injunction bid in IP suit against ex-BHP unit
Ex-BHP unit South32 has dodged a request for an expedited injunction barring in an intellectual property dispute, with a judge finding there was "no urgency" to the bid. 
Judge hearing Cbus case slams ‘false economy’ of concise statements
The judge hearing ASIC’s case against super fund Cbus has criticised the practice of exchanging concise statements and responses, saying it was a “false economy” of time and cost savings.
Cbus dragged to court by ASIC for $20M in claim delays
The superannuation fund of the construction industry has been hit with ASIC enforcement action, accused of long delays in processing the death and disability claims of thousands of members.
MobiSuper, ZIB Financial fined $250,000 for ‘misleading’ superannuation marketing
A judge has fined superannuation fund promoter MobiSuper and licensee ZIB Financial $250,000 for misleading marketing calls.
Pfizer, Merck Sharpe & Dohme reach global settlement in vaccine patent battle
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.
Death causes six-month delay of trial in Merck, Pfizer vaccine patent dispute
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer's expert witnesses.